Page last updated: 2024-12-06

nobiletin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nobiletin is a polymethoxyflavone found in citrus fruits, particularly in the peel of mandarins. It has attracted significant attention for its various pharmacological properties, including antioxidant, anti-inflammatory, anticancer, and neuroprotective effects. Research suggests that nobiletin may exert these effects by modulating various signaling pathways, such as the NF-κB, MAPK, and PI3K/Akt pathways. Nobiletin is naturally synthesized in citrus plants through a complex biosynthetic pathway involving the flavonoid biosynthesis pathway. The compound is extracted from citrus peels using various methods, including solvent extraction and chromatography. Due to its promising biological activities, nobiletin is being extensively studied for its potential therapeutic applications in various diseases, including cancer, Alzheimer's disease, and cardiovascular diseases.'

nobiletin : A methoxyflavone that is flavone substituted by methoxy groups at positions 5, 6, 7, 8, 3' and 4' respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72344
CHEMBL ID76447
CHEBI ID7602
SCHEMBL ID244029
MeSH IDM0052702

Synonyms (87)

Synonym
AC-1023
CHEMBL76447 ,
chebi:7602 ,
d65ilj7wly ,
unii-d65ilj7wly
HMS3393D09
BRD-K06753942-001-02-0
nsc618903
nsc-618903
flavone, 5,6,7,8,3',4'-hexamethoxy
NCI60_041691
SDCCGMLS-0066776.P001
ccris 9012
nsc 76751
MEGXP0_000930
4h-1-benzopyran-4-one,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-
nsc-76751
ACON1_000921
2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4h-1-benzopyran-4-one
4h-1-benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-
2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromen-4-one
nsc76751
smr000156231
MLS000574877
5,6,7,8,3',4'-hexamethoxyflavone
478-01-3
hexamethoxyflavone
nobiletin
MLS000759462
MLS000877030
cpd000156231
NCGC00095703-01
KBIOGR_001519
KBIO3_001922
SPECTRUM4_001020
SPECTRUM2_001697
SPBIO_001654
SPECTRUM3_000921
SPECTRUM1505268
NCGC00169228-01
HMS2051D09
2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one
LMPK12111468
NCGC00095703-02
2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4h-chromen-4-one
bdbm50338976
2-(3,4-dimethoxy-phenyl)-5,6,7,8-tetramethoxy-chromen-4-one
5,6,7,8,3'',4''-hexamethoxyflavone
4,5,6,7,8,9,10,11,12,13-decahydrocyclododeca[d]oxazole
A827343
3',4',5,6,7,8-hexamethoxyflavone
N0871
MLS001424129
HMS2234A09
AKOS015965334
CCG-38781
FT-0686667
HMS3373C14
SCHEMBL244029
NC00186
nobiletin [inci]
flavone, 3',4',5,6,7,8-hexamethoxy-
nobiletin [usp-rs]
hexamethoxyflavone [who-dd]
Q-100511
mfcd03273560
HY-N0155
CS-5518
nobiletin, analytical standard
DTXSID30197275 ,
sr-01000712262
SR-01000712262-5
HMS3651G20
3'4'5,6,7,8-hexamethoxyflavone
nobiletin (usp-rs)
dtxcid40119766
nobiletin, >=97%
nobiletin, 20% (technical grade)
2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4h-1-benzopyran-4-one, 9ci
SW197566-2
nobiletin (hexamethoxyflavone)
S2333
Q2402963
AS-17452
STL565829
NCGC00095703-06
gtpl12446

Research Excerpts

Overview

Nobiletin is a natural flavonoid isolated from the citrus peel that exhibits anti-cancer activity. Nobiletin improves insulin resistance and atherosclerosis in mice with metabolic dysfunction.

ExcerptReferenceRelevance
"Nobiletin is a natural flavonoid isolated from the citrus peel that exhibits anti-cancer activity."( Mechanistic Insights of Anti-Immune Evasion by Nobiletin through Regulating miR-197/STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer (NSCLC) Cells.
Jang, KJ; Kang, DY; Lee, JM; Sp, N, 2021
)
1.6
"Nobiletin is a dietary flavonoid that improves insulin resistance and atherosclerosis in mice with metabolic dysfunction. "( Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia.
Chhoker, SS; Edwards, JY; Fadzeyeva, E; Hanson, AA; Huff, MW; Morrow, NM; Mulvihill, EE; Sutherland, BG; Telford, DE; Trzaskalski, NA, 2022
)
3.61
"Nobiletin (NOB) is a herbal-derived agent with fascinating anti-cancer properties."( Nobiletin as an inducer of programmed cell death in cancer: a review.
Chang, Z; Chen, X; Huang, J; Lu, Q; Najafi, M, 2022
)
2.89
"Nobiletin is a polymethoxylated flavone from citrus fruit peels. "( Transcriptomics, molecular docking, and cross-resistance profiling of nobiletin in cancer cells and synergistic interaction with doxorubicin upon SOX5 transfection.
Abdelfatah, S; Adham, AN; Efferth, T; Fleischer, E; Naqishbandi, A; Sugimoto, Y, 2022
)
2.4
"Nobiletin (NOB) is a natural compound known to display anticancer effects, and our previous studies showed that NOB activates RORs to enhance circadian rhythms and promote physiological fitness in mice."( ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer.
Chen, Z; Eckel-Mahan, K; Ji, Z; Kang, JM; Kim, E; Kim, JA; Kim, YJ; Lee, HK; Ono, K; Paudel, KR; Smith, JA; Wirianto, M; Yoo, JY; Yoo, SH; Zhou, X, 2022
)
1.78
"Nobiletin is a natural nutrient (or polymethoxyflavonoid) in orange peels exerting a preventive effect against metabolic diseases. "( Hypoglycemic Effect of Nobiletin via Regulation of Islet β-Cell Mitophagy and Gut Microbiota Homeostasis in Streptozocin-Challenged Mice.
Li, Y; Liao, W; Shen, J; Wang, K; Wu, M; Ye, Z; Yuan, S; Zou, J, 2022
)
2.47
"Nobiletin is a flavonoid present in the dried mature pericarp of mandarin orange (Citrus reticulata Blanco), which is used to prepare Citri Renetulatae Pericarpium and can inhibit tumour growth and progression according to modern pharmacological studies."( Nobiletin inhibits breast cancer cell migration and invasion by suppressing the IL-6-induced ERK-STAT and JNK-c-JUN pathways.
Chen, JX; Guo, YB; Li, Q; Lv, LL; Ruan, M; Wu, Y; Xu, JY; Ying, HF; Zhang, CY; Zhang, KY; Zheng, L; Zhu, WH; Zhu, WR, 2023
)
3.07
"Nobiletin (NOB) is a naturally occurring compound, commonly found in citrus peel, that shows hepatoprotective and lipid-reducing effects. "( Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice.
Fan, C; Ke, Z; Li, H; Li, J; Tian, W; Yu, Q, 2023
)
3.8
"Nobiletin is a flavonoid found in the peel of Citrus sinensis (oranges). "( Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
Fan, C; Li, J; Mei, F; Wang, S; Xi, R; Yang, J; Yin, Q; Yu, Y; Zhang, S; Zhang, X, 2023
)
3.8
"Nobiletin (NOB) is a dietary polymethoxylated flavonoid with protective effects and activities against oxidative stress, inflammation and cardiovascular disorders."( Modulation of Fat Deposition-Gut Interactions in Obese Mice by Administrating with Nobiletin.
Du, C; Guo, J; Xu, Y; Zhao, C, 2023
)
1.86
"Nobiletin is a natural product with multiple physiological activities and is the main ingredient of "( Nobiletin with AIEE Characteristics for Targeting Mitochondria and Real-Time Dynamic Tracking in Zebrafish.
He, F; He, Y; Jin, T; Li, N; Wu, Y; Yang, D, 2023
)
3.8
"Nobiletin (NOB) is a natural polymethoxylated flavonoid derived from citrus peels."( Nobiletin Mitigates D-Galactose-Induced Memory Impairment via Improving Hippocampal Neurogenesis in Mice.
Li, B; Li, R; Li, Y; Ren, F; Sun, Y; Wang, H; Wang, X; Xiong, W, 2023
)
3.07
"Nobiletin (NOB) is a flavonoid with attractive pharmaceutical characteristics, including anti-Alzheimer's, anti-inflammation, and anti-cancer properties, but it has low solubility in water, resulting in reduced bioavailability. "( Novel Pharmaceutical Cocrystals and Solvate Crystals of Nobiletin, a Citrus Flavonoid with Potent Pharmacological Activity.
Hayashi, K; Ito, M; Noguchi, S; Suzuki, H; Tokunaga, S; Uchikoshi, C, 2023
)
2.6
"Nobiletin (NOB) is a potential hepatoprotective agent for the treatment of APAP-induced liver injury."( The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury.
Cai, Y; Chen, B; Fu, J; Hu, Y; Lai, E; Liang, Z; Liu, Y; Ning, J; Wei, M; Zheng, G, 2023
)
1.89
"Nobiletin (NOB) is a bioflavonoid compound isolated from citrus fruit peels. "( Effects of Nobiletin supplementation on the freezing diluent on porcine sperm cryo-survival and subsequent in vitro embryo development.
Almubarak, A; Jeon, Y; Lee, S; Yu, IJ, 2024
)
3.28
"Nobiletin (NOB) is a polymethoxylated flavonoid extracted from citrus fruits reported to have antioxidant, anti-inflammatory and anti-apoptotic effects."( Nobiletin enhances the survival of random pattern skin flaps: Involvement of enhancing angiogenesis and inhibiting oxidative stress.
Gao, W; Huang, Z; Jiang, C; Jiang, R; Lin, C; Lin, D, 2020
)
2.72
"Nobiletin is a derivative of citrus fruit that has been shown to attenuate the development of osteoarthritis and inhibit the expression of proinflammatory cytokines."( Nobiletin suppresses IL-21/IL-21 receptor-mediated inflammatory response in MH7A fibroblast-like synoviocytes (FLS): An implication in rheumatoid arthritis.
Dong, Q; Guo, S; Liu, Z, 2020
)
2.72
"Nobiletin is a polymethoxylated flavonoid isolated from citrus fruits with wide biological effects, including inhibition of reactive oxygen species (ROS) production and cell cycle regulation, important factors for oocyte in vitro maturation (IVM). "( Antioxidant Nobiletin Enhances Oocyte Maturation and Subsequent Embryo Development and Quality.
Cajas, YN; Cañón-Beltrán, K; González, EM; Gutiérrez-Adán, A; Ladrón de Guevara, M; Millán de la Blanca, MG; Ramos-Ibeas, P; Rizos, D, 2020
)
2.38
"Nobiletin is a naturally occurring flavonoid with the greatest abundance found in citrus peels."( Nobiletin: Targeting the Circadian Network to Promote Bioenergetics and Healthy Aging.
Chen, Z; Dowhan, W; Mileykovskaya, E; Yoo, SH, 2020
)
2.72
"Nobiletin is a polymethoxylated flavone present in citrus fruits, which has been reported to have inhibitory effects on tumorigenesis of cancers. "( Nobiletin promotes the pyroptosis of breast cancer via regulation of miR-200b/JAZF1 axis.
Jian, WJ; Li, Y; Wang, JG; Zhang, J, 2021
)
3.51
"Nobiletin is a natural flavonoid isolated from citrus peel that has anti-angiogenic activity."( Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.
Joung, YH; Kang, DY; Kim, WS; Lee, HK; Park, JH; Park, YM; Song, KD; Sp, N; Yang, YM, 2017
)
2.62
"Nobiletin (NOB) is a polymethoxylated flavone present in citrus fruits and has been reported to have anti-obesity effects."( Nobiletin induces brown adipocyte-like phenotype and ameliorates stress in 3T3-L1 adipocytes.
Lone, J; Parray, HA; Yun, JW, 2018
)
2.64
"Nobiletin is a fully methoxylated flavone that has demonstrated anticancer activity via multiple modes of action. "( Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes.
Androutsopoulos, VP; Arroo, RR; Ruparelia, K; Surichan, S; Tsatsakis, AM, 2018
)
3.37
"Nobiletin is a flavonoid derived from citrus peel that has anticancer activity."( Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.
Darvin, P; Kang, DY; Kim, DH; Kim, HJ; Lee, HG; Park, JH; Park, YM; Sp, N; Yang, YM, 2018
)
2.64
"Nobiletin (Nob) is a polymethoxylated flavonoid derived from citrus fruits that has been reported to exert antioxidant and antitumor effects."( Nobiletin alleviates palmitic acid‑induced NLRP3 inflammasome activation in a sirtuin 1‑dependent manner in AML‑12 cells.
Du, X; Li, X; Liu, G; Peng, Z; Wang, Z; Xing, D, 2018
)
2.64
"Nobiletin is an 0-methylated flavonoid found in citrus peels that have anticancer, antiviral, neuroprotective; anti-inflammatory activities and depending on the cell types exhibits both pro- or anti-apoptotic properties We have found that nobiletin decreases oxygen consumption by bovine brain isolated mitochondria in the presence of glutamate and malate and increases in the presence of succinate. "( Mitochondrial Target of Nobiletin's Action.
Jojua, N; Mikeladze, DG; Sepashvili, M; Sharikadze, N; Zhuravliova, E, 2016
)
2.18
"Nobiletin (Nob) is a major component among the most reported polymethoxyflavones (PMFs), which possesses multiple efficacious healthcare activities. "( Characteristic of interaction mechanism between β-lactoglobulin and nobiletin: A multi-spectroscopic, thermodynamics methods and docking study.
Chen, Y; Dan, Q; Ding, S; Li, B; Liang, H; Wu, D; Xiong, W; Zhan, F, 2019
)
2.19
"Nobiletin is a natural polymethoxylated flavone that confers antioxidative, anti-inflammatory and anti-apoptotic efficacies. "( Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway.
Chen, J; Guo, X; Hu, Q; Jiang, H; Li, Y; Yang, S; Zhang, BF, 2019
)
3.4
"Nobiletin is a one of the polymethoxyflavones contained in the peel of citrus fruits, such as Citrus depressa. "( Endothelium-independent vasodilator effects of nobiletin in rat aorta.
Kaneda, H; Kaneda, T; Omi, T; Otomo, R; Sasaki, N; Sato, T, 2019
)
2.21
"Nobiletin is a typical polymethoxyl flavone from citrus fruits that has anticancer properties, but the molecular mechanism of its inhibitory effects on the growth of p53-mutated SNU-16 human gastric cancer cells has not been explored. "( Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
Ahn, KS; Cho, M; Cho, SK; Moon, JY, 2013
)
3.28
"Nobiletin is a polymethoxylated flavone that is abundant in the peels of citrus fruits, such as Citrus unshiu (Satsuma mandarin) and Citrus sinensis. "( Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1β-treated hepatocytes.
Ikeya, Y; Machida, T; Mori, M; Murase, H; Nishino, H; Nishizawa, M; Okumura, T; Okuyama, T; Yamanishi, R; Yoshigai, E, 2013
)
2.29
"Nobiletin is a non-toxic dietary flavonoid that possesses anti-cancer properties. "( Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells.
Chen, AY; Chen, J; Chen, YC; Creed, A; Huang, H; Li, Z; Rankin, GO; Xu, G; Ye, X, 2014
)
3.29
"Nobiletin is a unique flavonoid having polymethoxy groups and has exhibited anti-inflammatory and antiobesity effects. "( Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes.
Cha, BY; Kim, HJ; Teruya, T; Woo, JT; Yonezawa, T,
)
3.02
"Nobiletin is a citrus polymethoxyflavonoid that suppresses tumor growth and metastasis, both of which depend on angiogenesis in previous studies."( Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2.
Chen, CJ; Chen, MK; Chien, SY; Hsieh, MJ; Yang, SF, 2015
)
2.58
"Nobiletin (NBT) is a major citrus flavonoid with various health benefits. "( Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis.
Gao, Z; Song, M; Wang, M; Wu, X; Xiao, H; Xu, F; Zhang, G; Zheng, J, 2015
)
2.16
"Nobiletin is a product of citrus peel known for cognitive-enhancing effects in various pharmacological and neurodegenerative disease models, yet, it is not well studied in non-lesioned animals and the type of memory that nobiletin can improve remains unclear."( Nobiletin improves emotional and novelty recognition memory but not spatial referential memory.
Bae, JR; Kang, J; Kim, SY; Kim, Y; Kim, YK; Kim, YR; Lee, J; Maeng, S; Shin, JW; Sohn, NW; Swanberg, KM, 2017
)
2.62
"Nobiletin is a flavonoid that, besides having anti-inflammatory and anti-tumoral activity, seems to exert protective effects on cardiovascular system."( Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB.
Barra, G; Borgia, F; Cimmino, G; Cirillo, P; Conte, S; De Palma, R; Pellegrino, G; Sasso, FC; Trimarco, B; Ziviello, F, 2017
)
2.62
"Nobiletin (NOB) is a major citrus polymethoxyflavone (PMF) with various beneficial biological activities. "( Nobiletin and its colonic metabolites suppress colitis-associated colon carcinogenesis by down-regulating iNOS, inducing antioxidative enzymes and arresting cell cycle progression.
Gao, Z; Li, F; Song, M; Sun, Y; Wang, M; Wu, X; Xiao, H; Zheng, J, 2017
)
3.34
"Nobiletin is a polymethoxylated flavone found in certain citrus fruits that exhibits various pharmacological effects including anti-inflammatory, antitumor and neuroprotective properties. "( Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice.
Cha, BY; Choi, SS; Lee, YS; Nagai, K; Saito, K; Teruya, T; Woo, JT; Yamaguchi, K; Yamakawa, H; Yonezawa, T, 2010
)
3.25
"Nobiletin is a citrus polymethoxyflavonoid that suppresses tumor growth and metastasis, both of which depend on angiogenesis. "( Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Ikeda, M; Ikekita, M; Kunimasa, K; Kuranuki, S; Ohta, T; Oikawa, T; Sato, M; Yamori, Y, 2010
)
3.25
"Nobiletin is a citrus flavonoid which possesses the flavone structure with six methoxy groups. "( Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction.
Kadota, A; Kanda, K; Liu, MC; Nishi, K; Nishimoto, S; Sugahara, T, 2012
)
3.26
"Nobiletin (NOB) is a polymethoxylated flavone present in citrus fruits and has been reported to have antitumor and anti-inflammatory effects. "( Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Cha, BY; Choi, BK; Choi, SS; Lee, YS; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T, 2013
)
3.28
"Nobiletin is a nonpeptide compound with a low molecular weight from a citrus fruit and has the activity to rescue bulbectomy-induced memory impairment. "( Mechanism of neurotrophic action of nobiletin in PC12D cells.
Fukunaga, K; Hinohara, Y; Kasahara, J; Kondo, S; Maruyama, Y; Matsuzaki, K; Mimaki, Y; Nagase, H; Ohizumi, Y; Sashida, Y; Tank, AW; Yamakuni, T, 2005
)
2.05
"Nobiletin is a polymethoxylated flavone found in certain citrus fruits. "( Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes.
Abe, D; Saito, T; Sekiya, K, 2007
)
3.23
"Nobiletin is a citrus polymethoxylated flavonoid extracted from Citrus depressa, and has several reported biological effects. "( Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Higuchi, T; Hirata, Y; Ishii, H; Ito, A; Kakutani, H; Masuda, Y; Nakagawa, Y; Takada, K, 2008
)
2

Effects

Nobiletin has six methoxy groups at the 3',4',5,6,7,8-positions, which are catalyzed by O-methyltransferases (OMTs) Nobiletin (NOB) has been demonstrated to possess antitumor and neuroprotective activities.

ExcerptReferenceRelevance
"Nobiletin has a suppressive effect on the differentiation of preadipocytes into adipocytes when cells were induced with a general differentiation cocktail such as insulin, IBMX, and dexamethasone."( Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction.
Kadota, A; Kanda, K; Liu, MC; Nishi, K; Nishimoto, S; Sugahara, T, 2012
)
3.26
"Nobiletin has therapeutic potential for alleviating myocardial IR injury associated with ACSL4- and NCOA4-related ferroptosis."( Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus.
Huang, Q; Lei, S; Qiu, Z; Tian, L; Xia, ZY; Zhang, Y, 2023
)
3.07
"Nobiletin has received much attention for its promising biological activities. "( Assessment of Oral Bioavailability and Biotransformation of Emulsified Nobiletin Using
Cao, Y; Feng, K; Ho, CT; Huang, G; Huang, Q; Ludescher, R; Xiao, J; Xin, Y; Zhang, M, 2020
)
2.23
"Nobiletin has six methoxy groups at the 3',4',5,6,7,8-positions, which are catalyzed by O-methyltransferases (OMTs)."( Expression and functional analysis of the nobiletin biosynthesis-related gene CitOMT in citrus fruit.
Kan, T; Kato, M; Ma, G; Seoka, M; Yahata, M; Yamawaki, K; Zhang, L, 2020
)
1.54
"Nobiletin (NOB) has been demonstrated to possess antitumor and neuroprotective activities."( Nobiletin protects against insulin resistance and disorders of lipid metabolism by reprogramming of circadian clock in hepatocytes.
Guo, R; Li, L; Liu, H; Liu, X; Mi, Y; Qi, G; Tian, H, 2018
)
2.64
"Nobiletin has protective effects on cardiovascular diseases, but the mechanism is not clear. "( Nobiletin reduces LPL-mediated lipid accumulation and pro-inflammatory cytokine secretion through upregulation of miR-590 expression.
Chen, YS; He, PP; Hu, LZ; Liu, J; Ouyang, XP; Shen, QQ; Su, H; Tang, CK; Wang, Y; Wen, M; Yang, JX; Zheng, XL; Zou, JQ, 2019
)
3.4
"Nobiletin has been reported to reduce the risk of prostate cancer, but the mechanism is not well understood."( Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells.
Chen, AY; Chen, J; Chen, YC; Creed, A; Huang, H; Li, Z; Rankin, GO; Xu, G; Ye, X, 2014
)
2.57
"Nobiletin (NOB) has been reported to elicit a variety of biological effects through its anti-oxidant and anti-inflammatory properties."( Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo.
Bai, X; Chen, L; Chen, R; Cui, L; Wang, L; Zhang, C; Zhang, J; Zhang, L; Zhang, X; Zhao, T; Zhao, X; Zhao, Y; Zhu, C, 2016
)
2.6
"Nobiletin has the potential to serve as an anti-metastatic agent for treating osteosarcoma."( Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.
Cheng, HL; Hsieh, MJ; Lin, CW; Lu, KH; Lue, KH; Yang, JS; Yang, SF, 2016
)
2.6
"Nobiletin has certain inhibitory effects on the proliferation of lung cancer cells both in vivo and in vitro. "( [Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells].
Luo, G; Zeng, Y; Zhang, YX; Zhou, LM; Zhu, L, 2009
)
2.06
"Nobiletin has a suppressive effect on the differentiation of preadipocytes into adipocytes when cells were induced with a general differentiation cocktail such as insulin, IBMX, and dexamethasone."( Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction.
Kadota, A; Kanda, K; Liu, MC; Nishi, K; Nishimoto, S; Sugahara, T, 2012
)
3.26
"Nobiletin has obvious antitumor effect on Heps, the main mechanism is to enhance the cellular immune function and induce apoptosis of tumor tissue."( [Antitumor effects of nobiletin on Heps and its mechanism].
Cheng, MY; Ge, H; Zhang, HQ, 2006
)
2.09

Actions

Nobiletin (NOB) displays neuroprotective effects and anti-depressant-like effects. Nobiletin was shown to suppress a range of well-established activatory mechanisms, including platelet aggregation, granule secretion, integrin modulation, calcium mobilization and thrombus formation.

ExcerptReferenceRelevance
"Nobiletin can inhibit neuroinflammation by inhibiting HMGB-1, pyroptosis-related proteins, and inflammatory cytokines, thus mitigating AD."( Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.
Chai, W; Mei, Z; Nie, H; Xiang, Z; Xu, R; Zhang, H; Zhang, J; Zhang, P, 2022
)
2.53
"Nobiletin (NOB) displays neuroprotective effects and anti-depressant-like effects."( Nobiletin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Promoting Autophagy via the AMPK Pathway.
Guo, Y; Jiang, P; Qiao, Y; Wang, H; Zhang, J, 2020
)
2.72
"Nobiletin is able to inhibit cardiomyocyte apoptosis and can consequently attenuate CME-induced myocardial injuries."( Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.
Liang, X; Lu, Y; Mao, Q; Wu, Y, 2019
)
2.68
"Nobiletin may suppress the induction of inducible nitric oxide synthase (iNOS), which synthesizes the inflammatory mediator nitric oxide (NO) in hepatocytes."( Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1β-treated hepatocytes.
Ikeya, Y; Machida, T; Mori, M; Murase, H; Nishino, H; Nishizawa, M; Okumura, T; Okuyama, T; Yamanishi, R; Yoshigai, E, 2013
)
1.57
"Nobiletin was shown to suppress a range of well-established activatory mechanisms, including platelet aggregation, granule secretion, integrin modulation, calcium mobilization and thrombus formation. "( Pharmacological actions of nobiletin in the modulation of platelet function.
Ali, MS; Crescente, M; Flora, GD; Gibbins, JM; Jones, CI; Moraes, LA; Roweth, H; Stainer, AR; Unsworth, AJ; Vaiyapuri, S, 2015
)
2.16
"Nobiletin did not activate any peroxisome proliferator-activated receptor (PPAR), indicating that the metabolic effects were PPAR independent."( Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
Allister, EM; Assini, JM; Charbonneau, A; Edwards, JY; Huff, MW; Koppes, JB; Lee, JK; Marette, A; Mulvihill, EE; Sawyez, CG; St-Pierre, P; Sutherland, BG; Telford, DE, 2011
)
2.53

Treatment

Treatment with nobiletin prevented the reduction in CaMKII, MAP2 and GluR1 protein levels in the hippocampal CA1 region, accompanied by restoration of both ERK and CREB phosphorylation. Treatment withnobiletin reduced ROS levels and apoptotic morphological changes by dual staining.

ExcerptReferenceRelevance
"Nobiletin treatment could significantly reduce lipid accumulation in high-fat/high-sucrose diet-fed mice."( Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism.
Huang, TQ; Jiang, ZM; Li, SZ; Lin, Y; Liu, EH; Yang, X; Yi, Y; Zhang, NN, 2023
)
3.07
"Nobiletin treatments significantly improved the islets survival through reduction of HIF-1α and ROS production and suppression of apoptosis, along with increased islets function."( Protective effect of nobiletin on isolated human islets survival and function against hypoxia and oxidative stress-induced apoptosis.
Al-Abdullah, IH; Azarpira, N; Geramizadeh, B; Ghahremani, MH; Jabbarpour, Z; Kaviani, M; Keshtkar, S; Motazedian, N; Motevaseli, E; Nikeghbalian, S; Shamsaeefar, A, 2019
)
1.55
"Nobiletin treatment on MDA-MB 231 cells reduces the expression of CXC chemokine receptor type 4 (CXCR4), which is highly expressed in cancer stem cell populations in tumor patients. "( Bioinformatics Studies Provide Insight into Possible Target and Mechanisms of Action of Nobiletin against Cancer Stem Cells.
Hermawan, A; Putri, H, 2020
)
2.22
"Nobiletin treatment significantly ameliorated obesity, alleviated the whitening of brown adipose tissue, and promoted browning of white adipose tissue in mice fed a high-fat diet."( Nobiletin activates thermogenesis of brown and white adipose tissue in high-fat diet-fed C57BL/6 mice by shaping the gut microbiota.
Chen, H; Cui, Z; Hu, Y; Kou, G; Li, P; Lyu, Q; Nyantakyiwaa Amoah, A; Seydou Traore, S, 2021
)
2.79
"Nobiletin treatment rapidly elevated the expression levels of beige-specific genes such as Cd137, Cidea, Tbx1, and Tmem26."( Nobiletin induces brown adipocyte-like phenotype and ameliorates stress in 3T3-L1 adipocytes.
Lone, J; Parray, HA; Yun, JW, 2018
)
2.64
"Nobiletin treatment of IL-10"( Nobiletin acts anti-inflammatory on murine IL-10
Bischoff, SC; Feilhauer, K; Gommeringer, S; Hagenlocher, Y; Held, A; Köninger, J; Lorentz, A, 2019
)
3.4
"Nobiletin treatment significantly abrogated high-glucose-induced glomerular mesangial cell proliferation."( Nobiletin suppresses high-glucose-induced inflammation and ECM accumulation in human mesangial cells through STAT3/NF-κB pathway.
Han, Y; Jia, K; Liu, Z; Tian, J; Zhao, F; Zhao, Z, 2019
)
2.68
"Nobiletin pre-treatment significantly deceased the infract size and number of apoptotic cells in the myocardium of MIRI rats, as determined by Terminal deoxynucleotidyl transferase dUTP nick end labeling staining. "( Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway.
Chen, J; Guo, X; Hu, Q; Jiang, H; Li, Y; Yang, S; Zhang, BF, 2019
)
3.4
"Nobiletin pre-treatment may alleviate MIRI probably via the attenuation of PI3K/AKT-mediated ERS-related myocardial apoptosis."( Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway.
Chen, J; Guo, X; Hu, Q; Jiang, H; Li, Y; Yang, S; Zhang, BF, 2019
)
3.4
"Nobiletin treatment effectively decreased ET plus SCF-induced Raf-1, MEK and ERK1/2 phosphorylation and also downregulated the forskolin-induced phosphorylation of CREB."( Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes.
Cha, BY; Kim, HJ; Teruya, T; Woo, JT; Yonezawa, T,
)
2.3
"Nobiletin treatment also promoted tumorsuppressive miR-200b level."( Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b.
Gao, XJ; Liu, HJ; Liu, JW; Xu, HT; Zhang, JJ; Zhang, QG, 2015
)
2.58
"Nobiletin treatment ameliorated cardiac dysfunction in the DCM group, as shown by the result of echocardiography and hemodynamic measurements."( Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.
Bian, ZY; Deng, W; Jin, YG; Tang, QZ; Wei, WY; Xiang, SZ; Yang, Z; Zhang, N, 2016
)
2.6
"The nobiletin treatment significantly reduced the plasma amylase levels, pancreatic myeloperoxidase activity, percentage of pancreatic necrosis, plasma proinflammatory factors, the generation of reactive oxygen species, cell apoptosis, tissue damage, and the expression of phosphorylated p38MAPK (p-p38MAPK) and p-AKT."( Nobiletin protects against murine l-arginine-induced acute pancreatitis in association with downregulating p38MAPK and AKT.
Huang, J; Liu, B; Zhang, B, 2016
)
2.36
"In nobiletin-treated SNU-16 cells the glucose-regulated protein 78 kDa (GRP78) mRNA level was induced most significantly among six proteins related to cell survival and death."( Nobiletin Induces Protective Autophagy Accompanied by ER-Stress Mediated Apoptosis in Human Gastric Cancer SNU-16 Cells.
Cho, SK; Moon, JY, 2016
)
2.39
"The nobiletin treatment prevented the reduction in CaMKII, MAP2 and GluR1 protein levels in the hippocampal CA1 region, accompanied by restoration of both ERK and CREB phosphorylation and CaMKII autophosphorylation."( Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
Fukunaga, K; Han, F; Mimaki, Y; Moriguchi, S; Nakajima, A; Ohizumi, Y; Sashida, Y; Shioda, N; Yamakuni, T; Yamamoto, Y; Yokosuka, A, 2009
)
2.28
"Treatment with nobiletin reduces ROS levels and apoptotic morphological changes by dual staining and decreases levels of lipid peroxides and glutathione content in H."( Nobiletin Inhibits Helicobacterium pylori Infection-Induced Gastric Carcinogenic Signaling by Blocking Inflammation, Apoptosis, and Mitogen-Activated Protein Kinase Events in Gastric Epithelial-1 Cells.
Li, L; Ling, P; Ouyang, Y, 2020
)
2.34
"Treatment with nobiletin in MCF-7 and T47D breast cancer cells inhibited angiogenesis markers, based on western blotting and RT-PCR."( Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.
Joung, YH; Kang, DY; Kim, WS; Lee, HK; Park, JH; Park, YM; Song, KD; Sp, N; Yang, YM, 2017
)
2.24
"Treatment with nobiletin and miR-590 mimic decreased cellular lipid accumulation, whereas treatment with miR-590 inhibitor increased cellular lipid accumulation."( Nobiletin reduces LPL-mediated lipid accumulation and pro-inflammatory cytokine secretion through upregulation of miR-590 expression.
Chen, YS; He, PP; Hu, LZ; Liu, J; Ouyang, XP; Shen, QQ; Su, H; Tang, CK; Wang, Y; Wen, M; Yang, JX; Zheng, XL; Zou, JQ, 2019
)
2.3
"Pre-treatment with nobiletin, with or without PI3K/AKT inhibitor LY294002, was performed at the onset of reperfusion."( Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway.
Chen, J; Guo, X; Hu, Q; Jiang, H; Li, Y; Yang, S; Zhang, BF, 2019
)
2.28
"Treatment with nobiletin increased OVA-specific IL-4 and IL-10 production."( Nobiletin Enhances Induction of Antigen-Specific Immune Responses in BALB/c Mice Immunized with Ovalbumin.
Maki, A; Mitani, M; Nakamoto, A; Nakamoto, M; Nii, Y; Sakai, T; Shuto, E; Urayama, K, 2019
)
2.3
"Treatment with nobiletin (10 or 50mg/kg) reversed the impairment of recognition memory and context-dependent fear memory in SAMP8 mice."( Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
Aoyama, Y; Kim, HC; Mimaki, Y; Nagai, T; Nakai, T; Nakajima, A; Nguyen, TT; Ohizumi, Y; Shin, EJ; Yamada, K; Yamada, S; Yokosuka, A, 2013
)
2.17
"Treatment with nobiletin (30 mg/kg) for 3 months reversed the impairment of short-term memory and recognition memory in 3XTg-AD mice."( Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Aoyama, Y; Kim, HC; Mimaki, Y; Nagai, T; Nakajima, A; Nam, Y; Ohizumi, Y; Shin, EJ; Yamada, K; Yokoi, T; Yokosuka, A, 2015
)
2.2
"Treatment with nobiletin notably attenuated hypoxia-induced EMT, invasion and migration in H1299 cells, accompanied with reduced Notch-1, Jagged1/2 expressions and its downstream genes Hey-1 and Hes-1."( Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b.
Gao, XJ; Liu, HJ; Liu, JW; Xu, HT; Zhang, JJ; Zhang, QG, 2015
)
2.2
"Treatment with nobiletin induced the activation of phosphorylated (p)‑Akt, p‑cAMP response element binding protein (CREB) and brain‑derived neurotrophic factor (BDNF) protein expression and reduced the levels of B‑cell lymphoma 2‑associated X protein (Bax) in isoflurane‑induced rats."( Nobiletin ameliorates isoflurane-induced cognitive impairment via antioxidant, anti-inflammatory and anti-apoptotic effects in aging rats.
Bi, J; Lei, W; Lu, J; Zhang, H, 2016
)
2.22
"Treatment with nobiletin reduced serum alanine aminotransferase and aspartate aminotransferase levels, improved hepatic structure, and suppressed hepatic interleukin (IL)‑1β, IL‑6 and tumor necrosis factor‑α production 24 h after LPS/GalN exposure."( Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
Chen, H; Gong, J; He, K; He, Z; Li, X; Liu, Y, 2016
)
2.22
"The treatment of Nobiletin resulted in significant inhibition of A549 cells proliferation in a dose-dependent manner. "( [Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells].
Luo, G; Zeng, Y; Zhang, YX; Zhou, LM; Zhu, L, 2009
)
0.96
"Treatment with nobiletin 24 h prior to CDDP administration showed a synergistic effect compared to the control."( Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation.
Fujii, M; Furukawa, T; Ito, A; Kameyama, K; Kitajima, M; Kubota, T; Kumai, K; Otani, Y; Saikawa, Y; Sato, T; Yano, M; Yoshida, M; Yoshimizu, N, 2004
)
0.97
"Post-treatment with nobiletin (5,6,7,8,3',4'-hexamethoxy flavone), which was purified from the fruit peel of Citrus sunki Hort. "( Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-kappaB and ROS production in LPS-activated RAW 264.7 cells.
Choi, SY; Hwang, JH; Kim, SJ; Ko, HC; Park, JG, 2007
)
2.11

Toxicity

ExcerptReferenceRelevance
" No other adverse effects were observed in the 90-day study."( An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar 'Ohta ponkan' (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity.
Nakajima, A; Nemoto, K; Ohizumi, Y, 2020
)
0.76
"Drug-induced nephrotoxicity is a frequent adverse event that contributes to acute kidney injury with tubular and/or glomerular lesions."( Interaction of nobiletin with methotrexate ameliorates 7-OH methotrexate-induced nephrotoxicity through endoplasmic reticulum stress-dependent PERK/CHOP signaling pathway.
Chen, Y; Li, C; Liu, B; Liu, G; Liu, L; Liu, R; Liu, Y; Lu, A; Lu, C; Song, Y; Song, Z, 2021
)
0.97

Pharmacokinetics

N nobiletin could affect the pharmacokinetic (PK) behavior of PTX and reverse drug resistance in vivo as well as the corresponding mechanisms.

ExcerptReferenceRelevance
"To prepare self-assemble nobiletin proliposomes and study its pharmacokinetic behavior in rats after ig administration, and nobiletin suspension was used as control, self-assemble nobiletin proliposomes were prepared by a new proliposome preparation method, their physicochemical properties including encapsulation efficiency, particle size and stability of formed liposome were determined."( [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
Lin, W; Yao, J; Zhou, JP, 2009
)
0.94
" The half-life of each of these compounds in the silkworm hemolymph was 18, 26 and 34 h, respectively."( Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.
Asami, Y; Hamamoto, H; Horie, R; Sekimizu, K, 2010
)
0.36
"These findings suggest that silkworms can be used as a model animal to easily identify compounds with appropriate pharmacokinetic behavior."( Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.
Asami, Y; Hamamoto, H; Horie, R; Sekimizu, K, 2010
)
0.36
"In this study, we wanted to explore whether nobiletin could affect the pharmacokinetic (PK) behavior of PTX and reverse drug resistance in vivo as well as the corresponding mechanisms."( Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
Feng, SL; Huo, S; Li, YZ; Liu, RM; Qu, B; Tian, Y; Xie, Y; Xu, P, 2020
)
2.26
"Accurate and sensitive UPLC-MS/MS method was developed for the detection of PTX, and was applied to the pharmacokinetic study in rats."( Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
Feng, SL; Huo, S; Li, YZ; Liu, RM; Qu, B; Tian, Y; Xie, Y; Xu, P, 2020
)
2

Compound-Compound Interactions

ExcerptReferenceRelevance
"The present study aimed to develop a strategy involving quantitative analysis of multicomponents by single marker in combination with high-performance liquid chromatography fingerprint qualitative analysis for performing the quality control of Aurantii Fructus."( Quantitative analysis of multicomponents by single marker combined with HPLC fingerprint qualitative analyses for comprehensive evaluation of Aurantii Fructus.
Cai, X; Huang, D; Lei, Y; Lin, M; Luo, K; Sun, Z; Tan, S; Wang, Y; Xia, X; Yan, J; Zhang, Y, 2020
)
0.56

Bioavailability

Nobiletin is a compound with high fat solubility, high bioavailability and low toxicity. Compared to nobiletin suspension, nobilet in liposomes possessed higher absorptive rate and longer MRT.

ExcerptReferenceRelevance
" They may have potential as agents for reversing multidrug resistance or for recovering the bioavailability of certain drugs."( Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
Matsuo, H; Morimoto, S; Ohnishi, A; Ohtani, H; Sawada, Y; Shoyama, Y; Takanaga, H; Yamada, S, 2000
)
0.31
" In conclusion, various beverages, especially teas, inhibit the function of SULT1A3, and therefore may have the potential to increase the bioavailability of orally administered substrates of SULT1A3, such as beta(2) agonists."( Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
Hiratsuka, A; Nishimuta, H; Ogura, K; Ohtani, H; Sawada, Y; Tsujimoto, M, 2007
)
0.34
" Compared to nobiletin suspension, nobiletin liposomes possessed higher absorptive rate and longer MRT, and the relative bioavailability was 264."( [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
Lin, W; Yao, J; Zhou, JP, 2009
)
1.01
" Although the impacts of NOB and TAN on glucose homeostasis and cholesterol regulation have been investigated in human clinical trials, much information is still lacking about the metabolism and oral bioavailability of these compounds in animals."( Pharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry.
Cesar, TB; Jackson, E; Manthey, JA; Mertens-Talcott, S, 2011
)
0.67
" After oral administration of NOB/SD, higher exposure of NOB was observed with increases of bioavailability and CNS distribution by 13- and sevenfold, respectively, compared with those of crystalline NOB."( Development of high-energy amorphous solid dispersion of nanosized nobiletin, a citrus polymethoxylated flavone, with improved oral bioavailability.
Hashimoto, N; Kawabata, Y; Ogawa, K; Onoue, S; Seto, Y; Takahashi, H; Uchida, A; Yamada, S; Yuminoki, K, 2011
)
0.61
" After oral administration of NOB/SD (2 mg NOB/kg) in rats, compared with crystalline NOB, improved pharmacokinetic behavior was observed with increases of bioavailability and hepatic delivery by ca."( Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
Asakawa, T; Hashimoto, N; Hiza, A; Kan, T; Nakamura, T; Ogawa, K; Onoue, S; Tsukaguchi, Y; Uchida, A; Yamada, S; Yuminoki, K, 2013
)
0.61
"Lots of active substances are hydrophobic materials at ambient and body temperatures, decreasing their bioavailability and posing great challenges to successful incorporation into medication and functional foods."( Enhancement of Anti-Inflammatory Properties of Nobiletin in Macrophages by a Nano-Emulsion Preparation.
Li, Z; Liao, W; Liu, Z; Mao, L; Ren, J; Sun, S; Ye, J; Zhang, T, 2018
)
0.74
" Owing to its high melting point and poor water solubility, the oral bioavailability of Nob needs to be improved via loading Nob on carriers."( Characteristic of interaction mechanism between β-lactoglobulin and nobiletin: A multi-spectroscopic, thermodynamics methods and docking study.
Chen, Y; Dan, Q; Ding, S; Li, B; Liang, H; Wu, D; Xiong, W; Zhan, F, 2019
)
0.75
" Subsequent in vivo tests demonstrated that CAGE significantly improved area under the concentration-time curve of NOB in vivo and NOB/CAGE sample showed 20-times higher bioavailability than oral administration of NOB crystal."( Transdermal delivery of nobiletin using ionic liquids.
Hattori, T; Inai, M; Itai, S; Iwao, Y; Kan, T; Kimura, SI; Mitragotri, S; Tagawa, H, 2019
)
0.82
"Approximately 40% of compounds in clinical drug development suffer from solubility and bioavailability challenges."( Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin.
Dey, S; Jain, V; Kesharwani, SS; Kumar, VA; Mallya, P; Sharma, S, 2020
)
2
" The absolute oral bioavailability of nobiletin in lean (22."( Comparative Analyses of Bioavailability, Biotransformation, and Excretion of Nobiletin in Lean and Obese Rats.
Cao, Y; Feng, K; Ho, CT; Huang, Q; Kan, Q; Xiao, J; Xin, Y; Yin, B; Zhang, M, 2020
)
1.06
" Based on the solubility, compatibility, and pseudoternary phase diagram tests, a nano-SNEDDS formulation composed of capryol 90-cremophor EL35-tcranscutol HP (CET) to codeliver TGP and N was developed, and this formulation increased the bioavailability of TGP by 435."( Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system.
Liu, ZQ; Mai, CT; Qu, B; Wang, XL; Xie, Y; Zheng, DC; Zhou, H, 2022
)
0.94
" The findings provided a nanoemulsion delivery system to increase the bioavailability of nobiletin in vitro and in vivo."( Characterization, stability, digestion and absorption of a nobiletin nanoemulsion using DHA-enriched phosphatidylcholine as an emulsifier in vivo and in vitro.
Huang, QR; Ju, SN; Shi, HH; Wang, YM; Xue, CH; Yang, JY; Zhang, TT; Zhao, YC, 2022
)
1.19
" However, the poor solubility and low bioavailability of NOB hinders its application."( The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury.
Cai, Y; Chen, B; Fu, J; Hu, Y; Lai, E; Liang, Z; Liu, Y; Ning, J; Wei, M; Zheng, G, 2023
)
1.17
" The bioavailability and hepatoprotective effects of NOB/SD were evaluated in vitro and in vivo."( The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury.
Cai, Y; Chen, B; Fu, J; Hu, Y; Lai, E; Liang, Z; Liu, Y; Ning, J; Wei, M; Zheng, G, 2023
)
1.17
" NOB/SD displayed significantly improved bioavailability in healthy Sprague Dawley (SD) rats in vivo."( The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury.
Cai, Y; Chen, B; Fu, J; Hu, Y; Lai, E; Liang, Z; Liu, Y; Ning, J; Wei, M; Zheng, G, 2023
)
1.17
"These results suggested that NOB/SD could be considered as a promising hepatoprotective nano-drug delivery system for attenuating APAP-induced acute liver injury with superior bioavailability and efficient hepatoprotection, which might provide an effective strategy for APAP-induced acute liver injury prevention and treatment."( The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury.
Cai, Y; Chen, B; Fu, J; Hu, Y; Lai, E; Liang, Z; Liu, Y; Ning, J; Wei, M; Zheng, G, 2023
)
1.17
" Nobiletin, as a compound with high fat solubility, high bioavailability and low toxicity, has been extensively studied."( A review on recent advances on nobiletin in central and peripheral nervous system diseases.
Ding, W; Pang, Y; Wu, Y; Xiong, J, 2023
)
2.11

Dosage Studied

Nobiletin (P<0.05% nobiletin) was found to be 14% in lewis mice treated with high (300 mg/kg), middle (200 mg/ kilograms) and low (100 mg/ kg) dosage of AOM. For the colonic bioconversion, more demethylated metabolites with higher biological activity were found in feces than nob toiletin. Maximum concentrations of nobiletIn in both plasma and brain were observed at 1h after single oral dosing (50mg/kg)

ExcerptRelevanceReference
"05% nobiletin for 5 weeks, starting one week before the first dosing of AOM."( Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
Kohno, H; Koshimizu, K; Murakami, A; Nishino, H; Ohigashi, H; Tanaka, T; Tokuda, H; Tsukio, Y; Yano, M; Yoshitani, S, 2001
)
1.15
"05% nobiletin for 34 weeks, starting one week after the last dosing of AOM."( Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats.
Kohno, H; Koshimizu, K; Murakami, A; Nishino, H; Ohigashi, H; Suzuki, R; Tanaka, T; Tokuda, H; Yano, M, 2004
)
1.34
"14% in lewis mice treated with high (300 mg/kg), middle (200 mg/kg), and low (100 mg/kg) dosage of Nobiletin (P<0."( [Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells].
Luo, G; Zeng, Y; Zhang, YX; Zhou, LM; Zhu, L, 2009
)
0.84
" Maximum concentrations of nobiletin in both plasma and brain were observed at 1h after single oral dosing (50 mg/kg)."( Permeability determination and pharmacokinetic study of nobiletin in rat plasma and brain by validated high-performance liquid chromatography method.
Jain, GK; Patel, K; Singh, SP; Tewari, D, 2011
)
0.91
" The hepatoprotective effects and pharmacokinetic behavior of orally dosed NOB/SD were evaluated in rats."( Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
Asakawa, T; Hashimoto, N; Hiza, A; Kan, T; Nakamura, T; Ogawa, K; Onoue, S; Tsukaguchi, Y; Uchida, A; Yamada, S; Yuminoki, K, 2013
)
0.61
" We conducted the excretion study and pharmacokinetics study of nobiletin via oral administration and intravenous injection and 15 day consecutive dosing study using the high fat diet-induced obese rats and their lean counterparts."( Comparative Analyses of Bioavailability, Biotransformation, and Excretion of Nobiletin in Lean and Obese Rats.
Cao, Y; Feng, K; Ho, CT; Huang, Q; Kan, Q; Xiao, J; Xin, Y; Yin, B; Zhang, M, 2020
)
1.03
" For the colonic bioconversion, more demethylated metabolites with higher biological activity were found in feces than nobiletin in the 48 h excretion study and 8 week consecutive dosing study."( Bidirectional interaction of nobiletin and gut microbiota in mice fed with a high-fat diet.
Ho, CT; Huang, Q; Li, D; Ma, YY; Zhang, M; Zhang, X; Zhao, DG; Zhu, J, 2021
)
1.12
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methoxyflavoneAny member of the class of flavones with at least one methoxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (40)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency21.20350.044717.8581100.0000AID485294; AID485341
Chain A, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency26.37630.177814.390939.8107AID2147
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
glp-1 receptor, partialHomo sapiens (human)Potency5.88920.01846.806014.1254AID624172; AID624417
phosphopantetheinyl transferaseBacillus subtilisPotency57.12200.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency25.92900.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency18.65610.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency25.11890.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.18380.011212.4002100.0000AID1030
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.50120.035520.977089.1251AID504332
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency28.18380.001815.663839.8107AID894
mitogen-activated protein kinase 1Homo sapiens (human)Potency21.42150.039816.784239.8107AID1454; AID995
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency79.43280.425612.059128.1838AID504891
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency11.22020.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency7.44860.004611.374133.4983AID624296; AID624297
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency25.11890.031610.279239.8107AID884; AID885
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency25.11890.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency35.48130.251215.843239.8107AID504327
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
TAR DNA-binding protein 43Homo sapiens (human)Potency17.78281.778316.208135.4813AID652104
GABA theta subunitRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)11.50000.00022.318510.0000AID681153
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)100.00000.00132.81389.8200AID399340
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)4.65000.00401.966610.0000AID578759; AID578760
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (69)

Processvia Protein(s)Taxonomy
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (103)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1866780Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human fibroblast cells supernatant assessed as inhibition of SCF mRNA expression at 20 uM and measured after 48 hrs by qRT-PCR analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID288088Cytotoxicity against human PMN cells at 100 uM2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID578843Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID681339TP_TRANSPORTER: inhibition of Estrone-3-sulfate uptake (Estrone-3-sulfate: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID404068In vivo antitumor activity against rat Walker 256 cells
AID724430Growth inhibition of human SRA 01/04 cells assessed as reduction in PCNA expression at 64 uM after 4 days by Western blot analysis2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Polymethoxyflavones as agents that prevent formation of cataract: nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells.
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID419239Induction of adipocyte differentiation in mouse ST-13 cells assessed as stimulation of adipocyte P2 mRNA expression at 0.1 to 30 uM within 11 days by semi-quantitative RT-PCR2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID333533Antimutagenic activity in Salmonella Typhimurium TA1535 carrying pSK1002 containing umuC'-lacZ fused gene assessed as suppression of Trp-P-1-induced SOS response to alteration in DNA synthesis measured by beta-galactosidase activity by Umu test2004Journal of natural products, Nov, Volume: 67, Issue:11
Biotransformation of nobiletin by Aspergillus niger and the antimutagenic activity of a metabolite, 4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone.
AID596669Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 0.3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID419235Induction of preadipocyte differentiation in mouse ST-13 cells assessed as lipid accumulation at 10 uM within 11 days by oil red-staining relative to control2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID1866783Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human fibroblast cells supernatant assessed as inhibition of LIF protein expression at 20 uM and measured after 48 hrs by Western blot analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID411504Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
AID578759Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1485946Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured up to 16 hrs by Thioflavin T based fluorescence assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID635945Inhibition of TNFalpha-stimulated pro MMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE based gelatin zymography assay2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production.
AID1101842Induction of resistance against Phytophthora citrophthora in Citrus (tangelo Nova) fruits assessed as increase of polymethoxyflavones levels at 20 to 250 ppm up to 160 days2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1387683Antimutagenic activity against Salmonella typhimurium TA98 assessed as inhibition of Trp-P-1-induced mutation at 80 nmol/plate measured in presence of S9 fraction by Ames test relative to control2018Journal of natural products, 10-26, Volume: 81, Issue:10
Structures and Antimutagenic Effects of Onoceranoid-Type Triterpenoids from the Leaves of Lansium domesticum.
AID330890Elevation of phosphorylated p38 level in hydrogen peroxide-treated human SHSY5Y cells at 30 uM after 3 hrs by Western blot analysis2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID578844Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID330888Reduction of hydrogen peroxide-induced apoptotic cell death in human SHSY5Y cells assessed as DNA ladder formation after 12 hrs2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID404008Cytotoxicity against human KB cells
AID419243Induction of adipocyte differentiation in mouse ST-13 cells assessed as increase in PPARgamma2 mRNA level after 11 days by semi-quantitative RT-PCR relative to control2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID309061Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 24 hrs2007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Anti-inflammatory property of the urinary metabolites of nobiletin in mouse.
AID1866777Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human fibroblast cells supernatant assessed as decrease in melanin content at 20 uM and measured after 48 hrs by Fontana-Masson staining based microscopic analy2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID609402Inhibition of PMA-induced proMMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE analysis2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Nobiletin metabolites: synthesis and inhibitory activity against matrix metalloproteinase-9 production.
AID333535Antimutagenic activity in Salmonella Typhimurium TA1535 carrying pSK1002 containing umuC'-lacZ fused gene assessed as suppression of 0.1 j/M2 UV light-induced SOS response to alteration in DNA synthesis measured by beta-galactosidase activity by Umu test2004Journal of natural products, Nov, Volume: 67, Issue:11
Biotransformation of nobiletin by Aspergillus niger and the antimutagenic activity of a metabolite, 4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone.
AID1101843Induction of resistance against Phytophthora citrophthora in Citrus (tangelo Nova) fruits assessed as increase of polymethoxyflavones levels at 20 to 250 ppm after 7 days2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1866786Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human HaCaT cells supernatant assessed as inhibition of SCF protein expression at 20 uM and measured after 48 hrs by Western blot analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID1866782Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human HaCaT cells supernatant assessed as inhibition of SCF mRNA expression at 20 uM and measured after 48 hrs by qRT-PCR analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID419237Induction of preadipocyte differentiation in mouse ST-13 cells assessed as triglyceride accumulation after 11 days by Fletcher's method2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID1101846Antifungal activity against Phytophthora citrophthora assessed as inhibition of radical growth at 0.05 to 0.4 g/L up to 200 hr2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1485950Inhibition of human amyloid beta (1 to 42) aggregation assessed as increase in preponderance of fibril meshwork formation at 100 uM after 48 hrs by transmission electron microscopic analysis2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1485953Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 1 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) ad2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID419241Induction of adiponectin secretion in mouse ST-13 cells at 10 uM after 11 days by ELISA relative to control2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID288086Antiproliferative activity against HL60 after 24 hrs2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID333534Antimutagenic activity in Salmonella Typhimurium TA1535 carrying pSK1002 containing umuC'-lacZ fused gene assessed as suppression of MeIQ-induced SOS response to alteration in DNA synthesis measured by beta-galactosidase activity by Umu test2004Journal of natural products, Nov, Volume: 67, Issue:11
Biotransformation of nobiletin by Aspergillus niger and the antimutagenic activity of a metabolite, 4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone.
AID724431Growth inhibition of human SRA 01/04 cells at 32 uM after 4 days by Alamar blue assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Polymethoxyflavones as agents that prevent formation of cataract: nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells.
AID609403Inhibition of TNF-alpha-induced proMMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE analysis2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Nobiletin metabolites: synthesis and inhibitory activity against matrix metalloproteinase-9 production.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID330889Elevation of phosphorylated ERK level in hydrogen peroxide-treated human SHSY5Y cells at 30 uM after 3 hrs by Western blot analysis2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID635947Inhibition of PMA-stimulated pro MMP9 production in human SRA 01/04 cells after 24 hrs by SDS-PAGE based gelatin zymography assay2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production.
AID144650In vitro cytotoxic potency against NCI-60 human tumor cell line1998Journal of medicinal chemistry, Jun-18, Volume: 41, Issue:13
Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
AID330887Reduction of hydrogen peroxide-induced apoptotic cell death in human SHSY5Y cells after 12 hrs2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID419244Agonist activity at Gal4-fused human PPARgamma expressed in african green monkey COS1 cells at 30 uM by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID419238Induction of adipocyte differentiation in mouse ST-13 cells assessed as stimulation of adipsin mRNA expression at 0.1 to 30 uM within 11 days by semi-quantitative RT-PCR2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID1866785Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human HaCaT cells supernatant assessed as inhibition of LIF protein expression at 20 uM and measured after 48 hrs by Western blot analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID680689TP_TRANSPORTER: increase in Vinblastine intracellular accumulation of Nobiletin at a concentration of 20uM in LLC-GA5-COL150 cells2004British journal of pharmacology, Dec, Volume: 143, Issue:7
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
AID1485945Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1866779Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human fibroblast cells supernatant assessed as inhibition of LIF mRNA expression at 20 uM and measured after 48 hrs by qRT-PCR analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID578765Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1866784Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human fibroblast cells supernatant assessed as inhibition of SCF protein expression at 20 uM and measured after 48 hrs by Western blot analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID419242Induction of adiponectin protein secretion in mouse ST-13 cells assessed as adiponectin mRNA level after 11 days by semi-quantitative RT-PCR2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID333536Antimutagenic activity in Salmonella Typhimurium TA1535 carrying pSK1002 containing umuC'-lacZ fused gene assessed as suppression of furyfuramide-induced SOS response to alteration in DNA synthesis measured by beta-galactosidase activity by Umu test2004Journal of natural products, Nov, Volume: 67, Issue:11
Biotransformation of nobiletin by Aspergillus niger and the antimutagenic activity of a metabolite, 4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone.
AID411503Anticancer activity against human HT-29 cells after 72 hrs by MTT assay2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
AID578760Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID681338TP_TRANSPORTER: inhibition of glibenclamide uptake (glibenclamide: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID1102050Antifeedant activity against Spodoptera litura F. by choice leaf disk assay2003Journal of agricultural and food chemistry, Jan-15, Volume: 51, Issue:2
Insect antifeedant activity of flavones and chromones against Spodoptera litura.
AID288087Apoptotic activity in HL60 cells after 24 hrs2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines.
AID309063Cytotoxicity against mouse RAW264.7 cells at 30 uM by MTT assay2007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Anti-inflammatory property of the urinary metabolites of nobiletin in mouse.
AID724432Growth inhibition of human SRA 01/04 cells at 64 uM after 4 days by Alamar blue assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Polymethoxyflavones as agents that prevent formation of cataract: nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells.
AID596671Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID1092127Antifungal activity against Aspergillus niger CICC 2273 assessed as inhibition of mycelial growth by microbroth dilution method2012Journal of agricultural and food chemistry, May-02, Volume: 60, Issue:17
Structure-activity relationship of citrus polymethoxylated flavones and their inhibitory effects on Aspergillus niger.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1866781Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human HaCaT cells supernatant assessed as inhibition of LIF mRNA expression at 20 uM and measured after 48 hrs by qRT-PCR analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID680673TP_TRANSPORTER: increase in saquinavir intracellular accumulation in the presence of Nobiletin at 20uM in LLC-GA5-COL150 cells2004British journal of pharmacology, Dec, Volume: 143, Issue:7
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
AID680684TP_TRANSPORTER: increase in Vinblastine uptake (Vinblastine: 0.02 uM, Nobiletin: 20 uM) in MDR1-expressing LLC-PK1 cells2000The Journal of pharmacology and experimental therapeutics, Apr, Volume: 293, Issue:1
Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
AID330891Elevation of phosphorylated JNk level in hydrogen peroxide-treated human SHSY5Y cells at 30 uM after 3 hrs by Western blot analysis2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
AID596673Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID681153TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells2001Chemical research in toxicology, Dec, Volume: 14, Issue:12
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
AID399646Antiinflammatory activity against rat assessed as inhibition of carrageenan-induced edema
AID404012In vivo antitumor activity against mouse LLC cells
AID419240Induction of adiponectin secretion in mouse ST-13 cells after 11 days by ELISA2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion.
AID596672Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID309062Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 30 uM after 24 hrs2007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Anti-inflammatory property of the urinary metabolites of nobiletin in mouse.
AID724433Growth inhibition of human SRA 01/04 cells after 4 days by Alamar blue assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Polymethoxyflavones as agents that prevent formation of cataract: nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells.
AID1101848Antifungal activity against Phytophthora citrophthora after 100 hr2002Journal of agricultural and food chemistry, May-08, Volume: 50, Issue:10
Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels.
AID1485955Cytotoxicity against rat PC12 cells assessed as reduction in cell viability at 100 uM after 48 hrs in presence of 0.1 uM amyloid beta (1 to 42) by MTT assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1866778Anti-melanogenic activity against human MNT-1 cells cocultured with 24 hrs compound pretreated human HaCaT cells supernatant assessed as decrease in melanin content at 20 uM and measured after 48 hrs by Fontana-Masson staining based microscopic analysis2022Journal of natural products, 04-22, Volume: 85, Issue:4
Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway.
AID596670Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1603991Growth inhibition of human HL60 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Nov-01, Volume: 181The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (469)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.21)18.7374
1990's12 (2.56)18.2507
2000's88 (18.76)29.6817
2010's234 (49.89)24.3611
2020's134 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.14 (24.57)
Research Supply Index6.17 (2.92)
Research Growth Index6.15 (4.65)
Search Engine Demand Index80.21 (26.88)
Search Engine Supply Index2.96 (0.95)

This Compound (38.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.21%)5.53%
Reviews22 (4.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other455 (95.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]